Evidence map›Paper›PMID 40229144›Full record

ReviewGeriatrics & gerontology international2025

Frailty, multimorbidity, and polypharmacy: Proposal of the new concept of the geriatric triangle.

Hiroyuki Umegaki

Abstract readReview
In one paragraph

Review in Geriatrics & gerontology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hiroyuki UmegakiDepartment of Community Healthcare and Geriatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0003-2504-4133

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As people age, the prevalence of frailty, multimorbidity, and polypharmacy increases, presenting significant challenges in geriatric medicine. These three elements are interrelated in a bidirectional manner, forming what can be termed the "geriatric triangle." The complexity of their interconnections means that addressing each issue in isolation is insufficient for achieving an effective resolution. Thus, a comprehensive understanding of this geriatric triangle is essential for appropriate geriatric management. This review aims to illuminate the relationships within the geriatric triangle and to offer insights into potential strategies for managing these interconnected challenges. Geriatr Gerontol Int 2025; 25: 657-662.

Indexed as

Frail ElderlyFrailtyMultimorbidityPolypharmacyAgedAged, 80 and overGeriatric AssessmentGeriatricsHumanscomprehensive geriatric assessmentgeriatric syndromepotentially inappropriate medicationssarcopenia

Identifiers

PMID40229144
PMCPMC12055515

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.